바로가기메뉴

본문 바로가기 주메뉴 바로가기
 
 

logo

  • ENGLISH
  • P-ISSN1226-6396
  • E-ISSN2234-4942
  • KCI

경도인지장애 환자의 장기간 한의약 치료 경과관찰 증례보고 2례

Long-Term Observations of Korean Medicine Treatment in Patients with Mild Cognitive Impairment: Two Case Reports

동의신경정신과학회지 / Journal of Oriental Neuropsychiatry, (P)1226-6396; (E)2234-4942
2021, v.32 no.3, pp.285-302
https://doi.org/10.7231/jon.2021.32.3.285
손성은 (광동한방병원 어지럼증.이명센터)
이고은 (국립재활의학센터 한방재활의학과)
이나현 (원광대학교 한의과대학 한방신경정신과교실)
유영수 (원광대학교 한의과대학 한방신경정신과교실)
정문주 (원광대학교 장흥통합의료병원 난치질환통합치료연구소)
강형원 (원광대학교 장흥통합의료병원 난치질환통합치료연구소)

Abstract

Objectives: To examine the effect of long-term Korean medicine treatment on mild cognitive impairment (MCI). Methods: This study was conducted on two patients who were diagnosed with mild cognitive impairment and received long-term Korean medicine treatment. In order to evaluate the degree of cognitive decline, SNSB and K-MMSE were performed 2~3 times at the first visit and during the treatment process. Results: Both cases 1 and 2 were diagnosed with MCI with a high possibility of developing dementia. In case 1, MCI progressed to early dementia at one year after the diagnosis of MCI. However, in case 2, that MCI status was maintained without progressing to dementia for 4 years after the diagnosis of MCI. The cause of such difference in the course of MCI might be attributed to the fact that Case 1 had lower K-IADL level but higher SGDS level than Case 2 at the time of initial diagnosis, with weak family support and irregular herbal medicine intake. Conclusions: Korean medicine treatment could improve and manage symptoms of cognitive decline due to MCI.

keywords
MCI, SNSB-2, Long-term Korean medicine treatment, Yisam-dan

동의신경정신과학회지